EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

World Media Directory · RSS · Email Newsletters

There were 1,886 press releases posted in the last 24 hours and 359,406 in the last 365 days.

Press Releases on May 14, 2025

1,642 Press Releases

Published on May 14, 2025 - 20:05 GMT

Toro Corp. Announces Full Repayment of the Senior Term Loan Granted to Castor Maritime Inc.

LIMASSOL, Cyprus, May 14, 2025 (GLOBE NEWSWIRE) -- Toro Corp. (NASDAQ: TORO) (“Toro”, or the “Company”), an international energy transportation services company, announces that on May 5, 2025, the senior term loan facility granted to Castor Maritime Inc. …

Distribution channels: Banking, Finance & Investment Industry ...
Published on May 14, 2025 - 20:05 GMT

Snail, Inc. Reports First Quarter 2025 Financial Results

CULVER CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, today announced financial results for its first …

Distribution channels: Business & Economy, IT Industry ...
Published on May 14, 2025 - 20:05 GMT

dLocal Reports 2025 First Quarter Financial Results

Record highs across key financial and operational metrics. TPV milestone of US$8 billion, +53% YoY and +5% QoQ. In constant currency, TPV increased +72% YoY. Revenue and gross profit record highs of US$217 million and US$85 million. Continued geographic …

Distribution channels: Business & Economy, Technology ...
Published on May 14, 2025 - 20:05 GMT

Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity

BOSTON and ATLANTA, May 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 14, 2025 - 20:03 GMT

Maine DOE, Educate Maine Announce 2025 County Teachers of the Year

On May 14 at the Hall of Flags, teachers representing all of the state’s 16 counties were announced as the 2025 Maine County Teachers of the Year. AUGUSTA, Maine—The State of Maine is celebrating its newest cohort of County Teachers of the Year. On …

Distribution channels:
Published on May 14, 2025 - 20:02 GMT

Interior to Initiate Action to Rescind BLM’s Intermittent Energy Rule

Date: May 14, 2025 Contact: Interior_Press@ios.doi.gov WASHINGTON — In alignment with President Trump’s agenda to eliminate burdensome regulations and stimulate economic growth, the Department of the Interior announced today the proposed rescission of a …

Distribution channels: Environment
Published on May 14, 2025 - 20:01 GMT

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Revenue for the First Quarter Ended March 31, 2025 was $13.1 million Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) Commercial Launch Off to a Strong Start, Initial Prescriptions Filled in Late March 2025 Phase 3 Clinical Trial Results …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 14, 2025 - 20:01 GMT

Office of the Governor — Flag Order — Gov. Green Lowers Flags In Observance Of Peace Officers Memorial Day

STATE OF HAWAIʻI KA MOKU ʻĀINA O HAWAIʻI JOSH GREEN, M.D. GOVERNOR KE KIAʻĀINA GOVERNOR GREEN LOWERS FLAGS IN OBSERVANCE OF PEACE OFFICERS MEMORIAL DAY FOR IMMEDIATE RELEASE May 14, 2025 HONOLULU – At the direction of the President of the United …

Distribution channels: U.S. Politics
Published on May 14, 2025 - 20:01 GMT

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Generated net FUROSCIX® revenue of $11.8 million in the first quarter of 2025 Formally launched FUROSCIX in second approved indication, Chronic Kidney Disease, in April 2025 Autoinjector on track for sNDA submission in Q3 2025; designed to reduce treatment …

Distribution channels: Business & Economy, Technology ...
Published on May 14, 2025 - 20:01 GMT

TMC Provides First Quarter 2025 Corporate Update

NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), a leading explorer of the world’s largest undeveloped resource of critical metals essential to energy, defense, manufacturing, and infrastructure …

Distribution channels: Business & Economy, Mining Industry ...
Published on May 14, 2025 - 20:01 GMT

Galapagos kondigt mondelinge presentaties aan tijdens EHA en ICML 2025 met veelbelovende nieuwe resultaten uit de ATALANTA-1 ...

Mechelen, België; 14 mei 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG), een wereldwijd biotechnologiebedrijf dat zich toelegt op het veranderen van de resultaten voor patiënten door middel van levensveranderende wetenschap en innovatie, …

Distribution channels: Media, Advertising & PR, Technology ...
Published on May 14, 2025 - 20:01 GMT

Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational ...

Mechelen, Belgium; May 14, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today announced that new data from our ongoing …

Distribution channels: Media, Advertising & PR, Technology ...
Published on May 14, 2025 - 20:01 GMT

Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights

Enrollment open in investigator-sponsored trial (IST) of NKX019 in myasthenia gravis; Ntrust-1, Ntrust-2, and IST of NKX019 in systemic lupus erythematosus remain open to enrollment Ntrust-1 expanded to include primary membranous nephropathy cohort …

Distribution channels: Business & Economy, Technology ...
Published on May 14, 2025 - 20:01 GMT

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on May 9, 2025, the compensation committee …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 14, 2025 - 20:01 GMT

Usio Announces First Quarter 2025 Financial Results

Record First Quarter Revenues of $22.0 million Total payment dollars processed through all payment channels up 34% versus the prior year period SAN ANTONIO, May 14, 2025 (GLOBE NEWSWIRE) -- Usio, Inc. (Nasdaq: USIO), a leading FinTech company that …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on May 14, 2025 - 20:01 GMT

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award

LOUISVILLE, Colo., May 14, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, is pleased to announce that it is a Colorado Top Workplaces 2025 Winner. The Top Workplaces program has an 18-year history of …

Distribution channels: Technology ...
Published on May 14, 2025 - 20:01 GMT

Senvest Capital Inc. annonce ses rėsultats pour le trimestre terminé le 31 mars 2025

MONTRĖAL, 14 mai 2025 (GLOBE NEWSWIRE) -- Senvest Capital Inc. a annoncé aujourd’hui un résultat net attribuable aux actionnaires ordinaires de (332,0 M$) ou (136,14 $) par action pour les trois mois terminés le 31 mars 2025. Pour la période correspondante …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on May 14, 2025 - 20:01 GMT

Senvest Capital Inc. Reports Results for the First Quarter Ended March 31, 2025

MONTREAL, May 14, 2025 (GLOBE NEWSWIRE) -- Senvest Capital Inc. today reported a net loss attributable to common shareholders of ($332.0) million or ($136.14) per share for the three months ended March 31, 2025. This compares to net income attributable to …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on May 14, 2025 - 20:01 GMT

Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones

MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease; Initial Data Expected in Q1 2026 MZE782 Phase 1 Healthy Volunteer Trial Ongoing; Initial Data Expected in Q3 2025 Strong Balance Sheet with $294.4 Million in Cash and Cash …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 14, 2025 - 20:01 GMT

Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference

VANCOUVER, British Columbia and BOSTON, May 14, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Previous 11 12 13 14 15 16 17 18 19 20 21 Next

Previous Day 2025 Calendar Next Day